Treatment failure rate, costs high in moderate-to-severe psoriasis

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.473, 2005-01, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment failure rate, costs high in moderate-to-severe psoriasis

By  

Inpharma, Vol. 1, Iss. 1479, 2005-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Cost-effectiveness of moderate-to-severe psoriasis treatment

By Miller Drew W   Feldman Steven R  

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 2, 2006-02 ,pp. : 157-167

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs for moderate-to-severe psoriasis

By Magliocco Melissa A  

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 1, 2005-02 ,pp. : 35-52

Informa Healthcare

Access to resources Recommend Favorite

Ustekinumab useful for moderate-to-severe plaque psoriasis

By  

Inpharma, Vol. 1, Iss. 1624, 2008-01 ,pp. : 3-4

Adis International

Access to resources Recommend Favorite

Pharmacological treatment in moderate-to-severe Alzheimer's disease

By Hsiung Ging-Yuek Robin   Feldman Howard H  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 15, 2008-10 ,pp. : 2575-2582

Informa Healthcare

Access to resources Recommend Favorite